Joshua D. Hamermesh

Chief Business Officer at Gamida Cell Ltd.

Joshua D. Hamermesh

Joshua D. Hamermesh

Chief Business Officer at Gamida Cell Ltd.

Overview
Career Highlights

MG Biotherapeutics LLC

RelSci Relationships

1262

Number of Boards

2

Birthday

1973

Age

48

Contact Data
Trying to get in touch with Joshua D. Hamermesh? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Joshua D. Hamermesh likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Gamida Cell Ltd.

Relationship likelihood: Strong

Director, President & Chief Executive Officer at LogicBio Therapeutics, Inc.

Relationship likelihood: Strong

Chief Scientific Officer at Gamida Cell Ltd.

Relationship likelihood: Strong

Acting Head, Clinical Trials at NeuroHealing Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Director at NeuroHealing Pharmaceuticals, Inc.

Relationship likelihood: Strong

Former President, Chief Executive Officer & Director at Targanta Therapeutics Corp.

Relationship likelihood: Strong

Chief Executive Officer at Unleash Immuno Oncolytics, Inc.

Relationship likelihood: Strong

Co-Founder at Tesorx Pharma LLC

Relationship likelihood: Strong

Former Vice President, Finance & Operations at Gamida Cell Ltd.

Relationship likelihood: Strong

Chief Financial Officer at Gamida Cell Ltd.

Relationship likelihood: Strong

Paths to Joshua D. Hamermesh
Potential Connections via
Relationship Science
You
Joshua D. Hamermesh
Chief Business Officer at Gamida Cell Ltd.
Education
BA, Economics

Amherst College educates men and women of exceptional potential from all backgrounds so that they may seek, value, and advance knowledge, engage the world around them, and lead principled lives of consequence. Amherst brings together the most promising students, whatever their financial need, in order to promote diversity of experience and ideas within a purposefully small residential community. Working with faculty, staff, and administrators dedicated to intellectual freedom and the highest standards of instruction in the liberal arts, Amherst undergraduates assume substantial responsibility for undertaking inquiry and for shaping their education within and beyond the curriculum. Amherst College is committed to learning through close colloquy and to expanding the realm of knowledge through scholarly research and artistic creation at the highest level. Its graduates link learning with leadership—in service to the College, to their communities, and to the world beyond.

MBA

Harvard Business School (HBS) is the graduate business school of Harvard University in Boston, Massachusetts, United States. The school offers a large full-time MBA program, doctoral programs, and many executive education programs. It owns Harvard Business School Publishing, which publishes business books, leadership articles, online management tools for corporate learning, case studies, and the monthly Harvard Business Review.

Career History
Chief Operating Officer-Mg BioTherapeutics Unit
1999 - 2005

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Senior Vice President, Strategy & Corporate Development
2009 - 2011

Pervasis Therapeutics, Inc. is a clinical stage company developing a broad portfolio of biologically active therapeutics. The company was founded by Robert S. Langer Jr. and Helen Marie Nugent in 2004 and is headquartered in Waltham, MA.

Professional
Prior

Guidant Corp. manufactures cardiovascular therapeutic devices. The company also provides cardiac and peripheral vascular repair surgical systems. It operates in Europe and Japan. Guidant was founded in 1994 and is headquartered in St. Paul, MN.

Boards & Committees
Independent Director
2021 - Current

LIPAC Oncology LLC engages in the provision of drug delivery services. It offers LiPax, a proliposomal intracavitary paclitaxel drug delivery platform. The company was founded by Ramachandran R. Thirucote, Willem A. Robberts and Michael Oefelein in 2016 and is headquartered in Pomona, CA.

Director
2014 - Current

NeuroHealing Pharmaceuticals, Inc. develops drug therapies for the post-acute and chronic neuro-rehabilitation patients. Its products include NH001, a dopaminergic agent to help post traumatic brain injury patients to emerge from a coma, vegetative, or minimally consciousness state, NH004, a treatment for the social debilitating condition of sialorrhea, a non-motor complaint of Parkinson's disease patients and NH02D, an orally administered drug for on-demand treatment of premature ejaculation, a male sexual disorder affecting sexually active men. The company was founded by Esteban Fridman and Daniel Katzman in 2003 and is headquartered in Waban, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Joshua D. Hamermesh. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Joshua D. Hamermesh's profile does not indicate a business or promotional relationship of any kind between RelSci and Joshua D. Hamermesh.